Oct. 13 (Thu.) ,2016 09:30-11:30

Annex Hall

Simultaneous Interpretation

Challenges for the Commercialization of
Regenerative Medicine in Japan

To promote the commercialization of Regenerative Medicine Products, the Act on the Safety of Regenerative Medicine and the revision of Pharmaceutical Affairs Law, came into effect on November, 2014. And last year, two new products were approved and reimbursed under the new legislation. However, several challenges for the commercialization still exist in Japan. In this session, from the outside of the industry, lecturers will give their explanation on the challenges and try to find the solution.


Yuji Tokumasu

Professor, Sub Director, Strategic Global Partnership and Cross-Inovation Initiative, OSAKA University Graduate School of Medicine / Osaka University Hospital

The Issues and Challenges of Regenerative Medicine in Japan Based on Global Trends

Shinichiro Sanji

Associate Partner, Industrial Strategy Group Leader, NTT DATA INSTITUTE OF MANAGEMENT CONSULTING

Outlook and Obstacles for Regenerative Medicine to Become a Profitable Industry

Hironoshin Nomura

Equity Research Senior Analyst, Mizuho Securities

Realize the Commercial Potential of Regenerative Medicine by Adopting the Right Legal Strategy

Chia-Feng Lu

Baker & McKenzie

Trends and Issues of Regenerative Medicine Venture Companies

Kanako Sogo

Assistant Vice President, Wholesale Banking Unit, Sumitomo Mitsui Banking Corporation

Close Window